{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:15:22Z","timestamp":1790158522305,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            This study examined the interaction between 5-hydroxytryptamine\n            <jats:sub>1B<\/jats:sub>\n            (5-HT\n            <jats:sub>1B<\/jats:sub>\n            ) receptors and 20-hydroxyeiscosatetraenoic acid (20-HETE) in contributing to the acute fall in regional cerebral blood flow (rCBF) after subarachnoid hemorrhage (SAH) in rats.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods\u2014<\/jats:italic>\n            <\/jats:bold>\n            The effects of intracisternal injection of 0.3 mL of arterial blood, artificial cerebrospinal fluid, and 5-HT on rCBF and the levels of 20-HETE and 5-HT in cerebrospinal fluid were measured in rats pretreated with vehicle, a 5-HT\n            <jats:sub>1B<\/jats:sub>\n            receptor antagonist (isamoltane hemifumarate), or an inhibitor of the synthesis of 20-HETE (HET0016). The effects of HET0016 and isamoltane on the vasoconstrictor response and changes in [Ca\n            <jats:sup>2+<\/jats:sup>\n            ]\n            <jats:sub>i<\/jats:sub>\n            to 5-HT were also studied in middle cerebral arteries and vascular smooth muscle cells isolated from these vessels.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            20-HETE and 5-HT levels in cerebrospinal fluid rose from 172\u00b110 to 629\u00b144 ng\/mL and from 6\u00b14 to 1163\u00b1200 nmol\/mL, respectively, after SAH. rCBF fell by 30% 10 minutes after SAH, and it remained at this level for the next 2 hours. Blockade of 5-HT\n            <jats:sub>1B<\/jats:sub>\n            receptors prevented the sustained fall in rCBF seen after SAH. Intracisternal injection of 5-HT mimicked SAH by increasing 20-HETE levels in cerebrospinal fluid to 475\u00b194 ng\/mL and reducing rCBF by 30%. Blockade of the synthesis of 20-HETE with HET0016 prevented the fall in rCBF produced by 5-HT. Isamoltane and HET0016 reduced the vasoconstrictor response of isolated MCA to 5-HT by &gt;60% and diminished the rise in [Ca\n            <jats:sup>2+<\/jats:sup>\n            ]\n            <jats:sub>i<\/jats:sub>\n            produced by 5-HT in vascular smooth muscle cells isolated from these arteries.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            These results suggest that the release of 5-HT after SAH activates 5-HT\n            <jats:sub>1B<\/jats:sub>\n            receptors and the synthesis of 20-HETE and that 20-HETE contributes to the acute fall in rCBF by potentiating the vasoconstrictor response of cerebral vessels to 5-HT.\n          <\/jats:p>","DOI":"10.1161\/01.str.0000065829.45234.69","type":"journal-article","created":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T20:14:41Z","timestamp":1051820081000},"page":"1269-1275","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":76,"title":["Contribution of 5-Hydroxytryptamine\n            <sub>1B<\/sub>\n            Receptors and 20-Hydroxyeiscosatetraenoic Acid to Fall in Cerebral Blood Flow After Subarachnoid Hemorrhage"],"prefix":"10.1161","volume":"34","author":[{"given":"Liana","family":"Cambj-Sapunar","sequence":"first","affiliation":[{"name":"From the Department of Physiology (L.C-S., M.Y., R.J.R.) and Cardiovascular Research Center (D.R.H.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yu","sequence":"additional","affiliation":[{"name":"From the Department of Physiology (L.C-S., M.Y., R.J.R.) and Cardiovascular Research Center (D.R.H.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Harder","sequence":"additional","affiliation":[{"name":"From the Department of Physiology (L.C-S., M.Y., R.J.R.) and Cardiovascular Research Center (D.R.H.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Roman","sequence":"additional","affiliation":[{"name":"From the Department of Physiology (L.C-S., M.Y., R.J.R.) and Cardiovascular Research Center (D.R.H.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.28.3.660"},{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.25.7.8023347"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/87.2.263"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.26.6.1086"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.16.4.4024174"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jon2000103157"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1998.78.1.53"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1995.82.1.0055"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01406495"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-9230(96)00345-0"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00924.2001"},{"key":"e_1_3_1_12_2","first-page":"A845.","volume":"16","year":"2002","unstructured":"Kehl F, Maier KG, Miyata N, Kametani S, Falck JR, Harder DR, Roman RJ. The 20-HETE antagonist WIT-002 attenuates the acute reduction of cerebral blood flow after subarachnoid hemorrhage (SAH) in the rat. FASEB J. 2002; 16: A845.Abstract.","journal-title":"FASEB J"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.13.2.7064189"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1967.26.2.0203"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1978.tb04586.x"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198110000-00010"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-198402000-00013"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702773"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703081"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.1.130"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0361-9230(01)00645-1"},{"key":"e_1_3_1_22_2","first-page":"609","volume":"337","year":"1988","unstructured":"Waldmeier PC, Williams M, Baumann PA, Bischoff S, Sills MA, Neale RF. Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1988; 337: 609\u2013620.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704101"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.2000.279.5.L863"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/clinchem\/42.7.1086","volume":"42","year":"1996","unstructured":"Pussard E, Guigueno N, Adam O, Giudicelli JF. Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine. Clin Chem. 1996; 42: 1086\u20131091.","journal-title":"Clin Chem"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.4.940"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1999.277.5.F790"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00699.2001"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1998.275.3.F370"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.30.12.2727"},{"key":"e_1_3_1_31_2","first-page":"R293","volume":"273","year":"1997","unstructured":"Oyekan A, Balazy M, McGiff JC. Renal oxygenases: differential contribution to vasoconstriction induced by ET-1 and ANG II. Am J Physiol. 1997; 273: R293\u2013R300.","journal-title":"Am J Physiol"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.87.9.818"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.1999.11740974"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.12.1.6784284"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1987.66.6.0915"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb10181.x"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00580870"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.87.1.60"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.0000065829.45234.69","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T20:28:38Z","timestamp":1715545718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.0000065829.45234.69"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1161\/01.STR.0000065829.45234.69"],"URL":"https:\/\/doi.org\/10.1161\/01.str.0000065829.45234.69","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"2002-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-04-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}